Atlas' 2022 fund, which raised the same amount and supported the launch of 16 companies, ended up backing four companies or programmes that went on to be acquired by big pharma groups (Nimbus ...

Repirinast is the Company’s lead candidate for the treatment of CKD based on data showing it reduced fibrosis by 51% with statistical significance and showed an additive benefit to telmisartan in a ...

The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Avadel Pharmaceuticals (AVDL – Research ...

Behind every name for a product or drug is someone writing hundreds of possible names. Lieba Golden-Koulendros made a career ...

An icon in the shape of a lightning bolt. Impact Link Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according ...

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Hundreds of children developed the disease in France in the last nine years (Picture: Shutterstock/Natchar Lai) A rare Renaissance-era condition known as ‘Sailor’s disease’ is making a ...

Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...

Sanofi S.A. Part Cert 0.06% €8.19M ...